Related Experiment Video
Updated: Sep 29, 2026
Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease
Published on: August 9, 2024
Noninvasive evaluation of women with coronary artery disease
1Baylor Heart Clinic, Baylor College of Medicine, Houston, Texas 77030, USA. karlak@bcm.tmc.edu
Insights
Coronary artery disease (CAD) is the leading cause of death for women, with diagnosis being challenging due to physiological differences. Recent advancements in echocardiography and Tc-99m sestamibi imaging offer improved diagnostic and prognostic capabilities for women with CAD.
Area of Science:
- Cardiology
- Medical Imaging
Background:
- Coronary artery disease (CAD) is the primary cause of mortality in women globally.
- Unlike men, the mortality rate from CAD in women has remained stagnant over the past two decades.
- Significant knowledge gaps exist regarding the prevention, diagnosis, and treatment of CAD specifically in the female population.
Purpose of the Study:
- To review recent advancements in noninvasive diagnostic imaging techniques for CAD in women.
- To explore the evolving role of echocardiography and Tc-99m sestamibi SPECT in diagnosing and prognosing CAD in women.
- To address the challenges in noninvasive CAD diagnosis in women due to physiological and clinical differences compared to men.
Main Methods:
- Review of current literature on noninvasive imaging modalities for CAD in women.
- Analysis of echocardiography and Tc-99m sestamibi single-photon emission computed tomography (SPECT) imaging techniques.
- Consideration of pharmacologic stress agents (dobutamine, adenosine, dipyridamole) used in conjunction with imaging.
Main Results:
- Echocardiography and Tc-99m sestamibi SPECT have been adapted to account for female-specific physiological differences.
- These imaging techniques, when combined with stress protocols, show promise in improving the accuracy of CAD diagnosis in women.
- Evolved imaging protocols enhance the diagnostic and prognostic value for women presenting with suspected or known CAD.
Conclusions:
- Noninvasive imaging plays a crucial role in the diagnosis and prognosis of CAD in women.
- Advancements in echocardiography and Tc-99m sestamibi SPECT are vital for overcoming diagnostic challenges in this demographic.
- Further research and application of these evolved techniques are essential for improving outcomes for women with CAD.
Abstract:
Coronary artery disease (CAD) is the leading cause of death in women. More women than men die of CAD each year, and unlike men, the death rate has not declined for women but has remained stable over the last 20 years. Despite these statistics, much less is known about the prevention, diagnosis, or treatment of CAD in women. The noninvasive diagnosis of CAD in women is difficult secondary to differences in physiology, etiology, presenting symptoms, risk factor prevalence, comorbid conditions, hormonal status, and body habitus between women and men. Echocardiography and Tc-99m sestamibi single photon emission computed tomography imaging are two noninvasive imaging techniques commonly combined with exercise or pharmacologic agents (dobutamine, adenosine, dipyridamole) that have recently evolved to address these differences. These evolutions and the role of both techniques in the diagnosis and prognosis of women with CAD will be reviewed in this article.
Related Concept Videos
01:30Acute Coronary Syndrome III: Diagnostic Studies
01:25Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
01:27Coronary Artery Disease V: Interprofessional Care
01:29Angina III: Clinical Manifestations and Assessment
01:28Imaging Studies for Cardiovascular System V: CT
01:17Imaging Studies for Cardiovascular System I:Echocardiography
Indications: Echocardiography is utilized to diagnose heart failure, valve disorders, and myocardial infarction. It also assesses cardiac structures' size, shape, and motion, evaluates...